Consortium study on 1280 breast carcinomas: Allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters

Cancer Research

Volumn 58, Issue 5, 1998, Pages 1004-1012

  Phelan, Catherine M ^a,r   Borg, Åke ^b   Cuny, Marguerite ^c   Crichton, David N ^d   Baldersson, Trausti ^e   Andersen, Tone Ikdahl ^f,g   Caligo, Maria Adelaide ^h   Lidereau, Rosette ⁱ   Lindblom, Annika ^a   Seitz, Susanne ^j   Kelsell, David ^k   Hamann, Ute ^l   Rio, Pascale ^m   Thorlacius, Steinunn ⁿ   Papp, Janos ^o   Olah, Edith ^o   Ponder, Bruce ^p   Bignon, Yves Jean ^m   Scherneck, Siegfried ^j   Barkardottir, Rosa ^e   Borresen Dale, Anne Lise ^f   Eyfjörd, Jorunn ⁿ   Theillet, Charles ^c   Thompson, Alastair M ^d   Devilee, Peter ^q   Larsson, Catharina ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f INSTITUTE OF CANCER RESEARCH   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY OF PISA   (Italy)

ⁱ CENTRE RENÉ HUGUENIN   (France)

^j MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^k IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m CENTRE JEAN PERRIN   (France)

ⁿ ICELANDIC CANCER SOCIETY   (Iceland)

^o NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^p CRC Department of Pathology   (United Kingdom)

^q LEIDEN UNIVERSITY   (Netherlands)

^r UNIVERSITY COLLEGE DUBLIN   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CHROMOSOME 17; CHROMOSOME DELETION; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MONOSOMY; ONSET AGE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; ALLELES; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 0032032656     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Murphy, D., McHardy, P., Coutts, J., Mallon, E., George, W., Kaye, S., Brown, R., and Keith, W. Interphase cytogenetic analysis of erbB2 and topoll α co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int. J. Cancer, 64: 18-26, 1995.
2. Herrington, C., Leek, R., and McGee, J. Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J. Pathol., 176: 353-359, 1995.
3. Theile, M., Hartmann, S., Scherthan, H., Arnold, W., Deppert, W., Frege, R., Glaab, F., Haensch, W., and Scherneck, S. Suppression of tumourigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene, 10: 439-447, 1995.
4. Negrini, M., Sabbioni, S., Haldar, S., Possati, L., Castagnoli, A., Corallini, A., Barbanti-Brodano, G., and Croce, C. Tumour and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res., 54: 1818-1824, 1994.
5. Casey, G., Plummer, S., Hoeltge, G., Scanlon, D., Fasching, C., and Stanbridge, E. Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Hum. Mol. Genet., 2: 1921-1927, 1993.
6. Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M., Chenard, M., Lidereau, R., Basset, P., and Rio, M. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics, 28: 367-376, 1995.
7. Tripathy, D., and Benz, C. Activated oncogenes and putative tumour suppressor genes involved in human breast cancers. Cancer Treat. Res., 63: 15-60, 1992.
8. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Chetty, U., Mackay, J., Macdonald, M., Nakamura, Y., Hoyheiim, B., and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336: 761-763, 1990.
9. Andersen, T., Gaustad, A., Ottestad, L., Farrants, G., Nesland, J. M., Tveit, K., and Borresen, A. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 17, and 17q in human breast carcinomas. Genes Chromosomes Cancer, 4: 113-121, 1992.
10. Cornelis, R. S., van Vliet, M., Vos, C. B. J., Cleton-Janson, A-M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Borresen, A-L., Cornelisse, C. J., and Devilee, P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumours without p53 mutations. Cancer Res., 54: 4200-4206, 1994.
11. Nagaj, M., Medeiros, A., Brentani, M., Brentani, R., Marques, L., Mazoyer, S., and Mulligan, L. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumours. Oncology, 52: 448-453, 1995.
12. Callahan, R., Cropp, C., Merlo, G., Diella, F., Venesio, T., Lidereau, R., Cappa, A., and Lisicia, D. Genetic and molecular heterogeneity of breast cancer cells. Clin. Chim. Acta, 217: 63-73, 1993.
13. Cogen, P. H., Daneshvar, L., Metzger, A. K., and Edwards, M. S. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene, 5: 1573-1579, 1990.
14. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
15. Schultz, D., Vanderveer, L., Herman, D., Hamilton, T., Wong, A., and Godwin, A. A candidate tumour suppressor gene for ovarian cancer on chromosome 17p13.3. Am. J. Hum. Genet., 57: A4, 1995.
16. Phillips, N., Ziegler, M., Radford, D., Fair, K., Steinbrueck, T., Xynos, F., and Donnis-Keller, H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res., 56: 606-611, 1996.
17. Kirchweger, R., Zeillinger, R., Schneeberger, C., Speiser, P., Louason, G., and Theillet, C. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int. J. Cancer, 56: 193-199, 1994.
18. Yang-Feng, T., Han, H., Chen, K., Li, S., Claus, E., Carcangui, M., Chambers, S., Chambers, J., and Schwartz, P. Allelic loss in ovarian cancer. Int. J. Cancer, 54: 546-551, 1993.
19. Cavalli, L., Rogatto, S., Rainho, C., dos Santos, M., Cavalli, I., and Grimaldi, D. Cytogenetic report of a male breast cancer. Cancer Genet. Cytogenet., 81: 66-71, 1995.
20. Cropp, C., Nevanlinna, H., Pyrhonen, S., Stenman, U., Salmikangas, P., Albertsen, H., White, R., and Callahan, R. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res., 54: 2548-2551, 1994.
21. Velu, T. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
22. Borg, A., Zhang, Q-X., Johansson, O., and Olsson, H. High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas. J. Natl. Cancer Inst., 86: 92-94, 1994.
23. Cornelis, R., Devilee, P., van Vliet, M., Kuipers-Dijkshoom, N., Kersenmaeker, A., Bardoel, A., Khan, P., and Cornelisse, C. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene, 8: 781-785, 1993.
24. Cropp, C., Champene, M-H., Lidereau, R., and Callahan, R. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res., 53: 5617-5619, 1993.
25. Friedman, L., Ostermeyer, E., Lynch, E., Welsch, P., Szabo, C., Meza, J., Anderson, L., Dowd, P., Lee, M., and Rowell, S. 22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumours. Genomics, 25: 256-263, 1995.
26. Futreal, P., Soderkvist, P., Marks, J., Iglehart, J., Cochran, C., Barrett, J., and Wiseman, R. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res., 52: 2624-2627, 1992.
27. Godwin, A., Vanderveer, L., Schultz, D., Lynch, H., Altomare, D., Buetow, K., Daly, M., Getts, L., Masny, A., Rosenblum, N., Hogan, M., Ozols, R., and Hamilton, T. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumours distal to BRCA1. Am. J. Hum. Genet., 55: 666-677, 1994.
28. Lindblom, A., Skoog, L., Andersen, T., Rotstein, S., Nordenskjöld, M., and Larsson, C. Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas. Hum. Genet., 91: 6-12, 1993.
29. Radford, D., Fair, K., Thompson, A., Ritter, J., Holt, M., Steinbrueck, T., Wallace, M., Wells, S., and Donis-Keller, H. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res., 53: 2947-2949, 1993.
30. Watatani, M., Nagamaya, K., Imanishi, Y., Kurooka, K., Wada, T., Inui, H., Hirai, K., Ozaki, M., and Yasutomi, M. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Res. Treat., 28: 231-239, 1993.
31. Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McLure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J., Marks, J., Ballinger, D. G., Barrett, J., Skolnick, M., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
32. Thompson, M., Jensen, R., Obermiller, P., Page, D., and Holt, J. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995.
33. Merajver, S., Pham, T., Caduff, R., Chen, M., Poy, E., Cooney, K., Weber, B., Collins, F., Johnston, C., and Frank, T. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439-443, 1995.
34. Hosking, L., Trowsdale, J., Nicolai, H., Solomon, E., Foulkes, W., Stamp, G., Signer, E., and Jeffreys, A. A somatic BRCA1 mutation in an ovarian tumour. Nat. Genet., 9: 343-344, 1995.
35. Sato, T., Saito, H., Swensen, J., Olifant, A., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., and Miki, Y. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52: 1643-1646, 1992.
36. Emi, K., Katagiri, T., Harada, Y., Saito, H., Inazawa, J., Ito, I., Kasumi, F., and Nakamura, Y. A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nat. Genet., 5: 151-157, 1993.
37. Russo, J., and Russo, I. The pathology of breast cancer: staging and prognostic indicators. J. Am. Med. Womens Assoc., 47: 181-187, 1992.
38. Hutter, R. Worldwide agreement on the staging of cancer. Arch. Surg., 122: 1235-1246, 1987.
39. Piccirillo, J. F., and Feinstein, A. R. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer (Phila.), 77: 834-842, 1996.
40. Hamann, U., Costa, S. D., Göttne, K., Huober, J., Solomayer, E-F., Kaufmann, M., Bastert, G., and Komitowski, D. Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. Breast, 60: 1-5, 1997.
41. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137: 266-267, 1984.
42. Gyapay, G., Morisette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Généthon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
43. Merlo, G., Venesio, T., Bernardi, A., Cropp, C., Diella, F., Cappa, A., Callahan, R., and Liscia, D. Evidence for a second tumour suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas. Cancer Genet. Cytogenet., 76: 106-111, 1994.
44. Ito, I., Yoshimoto, M., Iwase, T., Watanabe, S., Katagiri, T., Harada, Y., Kasumi, F., Yasuda, S., Mitomi, T., and Emi, M. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br. J. Cancer, 71: 438-441, 1995.
45. Lindblom, A., Rotstein, S., Skoog, L., Nordenskjöld, M., and Larsson, C. Deletions of chromosome 16 in primary familial breast carcinomas are associated with development of distant metastasis. Cancer Res., 53: 3707-3711, 1993.
46. Prosser, J., Elder, P., Condie, A., MacFayden, I., Steel, C., and Evans, H. Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br. J. Cancer. 63: 181-184, 1991.
47. Human gene mapping 11.0 proceedings. Cytogenet. Cell Genet., 51: Vols. 1-4, 1991.